Trial Profile
Bridging study evaluating the immunogenicity and safety of a trivalent seasonal influenza HA vaccine [FluBio] in adolescents and adults
Status:
Completed
Phase of Trial:
Phase II/III
Latest Information Update: 19 May 2014
Price :
$35
*
At a glance
- Drugs Influenza HA vaccine (Flubio) (Primary)
- Indications Influenza A virus infections; Influenza B virus infections
- Focus Adverse reactions; Pharmacodynamics
- 19 May 2014 New trial record